Article
VEGFR2 Gene Polymorphisms and Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration.
Ophthalmology - 1 Aug 2015
Hagstrom Stephanie A, Ying Gui-shuang, Maguire Maureen G, Martin Daniel F, Gibson Jane, Lotery Andrew, Chakravarthy Usha
Abstract excerpt
PURPOSE: A previously published study demonstrated a pharmacogenetic association between the minor alleles of 2 VEGFR2 single nucleotide polymorphisms (SNPs) and greater improvement in visual acuity (VA) to treatment with ranibizumab, an anti-vascular endothelial growth factor (VEGF) drug, in patients with neovascular age-related macular degeneration (AMD). We evaluated whether this association was replicated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
